“Hepatic Adverse Effects and Genetic Polymorphisms of NAT2 and CYP2C9”. Precision Medicine Communications, vol. 1, no. 1, Dec. 2021, pp. 05-07, https://doi.org/10.55627/pmc.001.01.0072.